Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized placebo-controlled study of plasma therapy in septic shock-induced coagulopathy
2019-004769-41Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in coagulopathy comparing OctaplasLG plasma therapy with Placebo (2 arms). Primary endpoints: Feasibility of timely randomization and Feasibility of timely treatment initiation. Started Dec 2020; status: completed.
02
Drugs
octaplas lg
03
Conditions
coagulopathy
Beyond the preview
Go deeper on 2019-004769-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004769-41.